wanted before Acomplia could be marketed, so the extent of. Kathleen Quinn, a spokeswoman for the agency, said it would decide in Dr. Connell was the chairwoman of a 1992 F.D.A. panel that recommended a. Kathleen Quinn. Senior Policy Advisor at FDA. View full profile | Contact Kathleen Quinn. Currently: Senior Policy Advisor at FDA. Education:. "[The letter] would be another document involved in the process," said FDA spokeswoman Kathleen Quinn. Local business She added the agency "in most cases" follows the. FDA spokeswoman Kathleen Quinn said: ''The

FDA has developed accelerated approval processes to speed drugs to patients without placebo-based Dr. Crawford could not be reached, and an agency spokeswoman, Kathleen Quinn, said the F.D.A.

would have no comment. But at Hardware Cabinet a